Literature DB >> 22080216

A simple screening method using ion chromatography for the diagnosis of cerebral creatine deficiency syndromes.

Takahito Wada1, Hiroko Shimbo, Hitoshi Osaka.   

Abstract

Cerebral creatine deficiency syndromes (CCDS) are caused by genetic defects in L-arginine:glycine amidinotransferase, guanidinoacetate methyltransferase or creatine transporter 1. CCDS are characterized by abnormal concentrations of urinary creatine (CR), guanidinoacetic acid (GA), or creatinine (CN). In this study, we describe a simple HPLC method to determine the concentrations of CR, GA, and CN using a weak-acid ion chromatography column with a UV detector without any derivatization. CR, GA, and CN were separated clearly with the retention times (mean ± SD, n = 3) of 5.54 ± 0.0035 min for CR, 6.41 ± 0.0079 min for GA, and 13.53 ± 0.046 min for CN. This new method should provide a simple screening test for the diagnosis of CCDS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22080216     DOI: 10.1007/s00726-011-1146-1

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  3 in total

1.  A Japanese adult case of guanidinoacetate methyltransferase deficiency.

Authors:  Tomoyuki Akiyama; Hitoshi Osaka; Hiroko Shimbo; Tomoshi Nakajiri; Katsuhiro Kobayashi; Makio Oka; Fumika Endoh; Harumi Yoshinaga
Journal:  JIMD Rep       Date:  2013-07-12

2.  Clinical Evaluation of a Novel Urine Collection Kit Using Filter Paper in Neonates: An Observational Study.

Authors:  Nobuhiko Nagano; Takayuki Imaizumi; Takuya Akimoto; Midori Hijikata; Ryoji Aoki; Ayako Seimiya; Aya Okahashi; Kaori Kawakami; Atsushi Komatsu; Kei Kawana; Ichiro Morioka
Journal:  Children (Basel)       Date:  2021-06-29

3.  Effects of dietary guanidinoacetic acid on growth performance, guanidinoacetic acid absorption and creatine metabolism of lambs.

Authors:  Shiqi Zhang; Changjiang Zang; Jun Pan; Chen Ma; Caidie Wang; Xiaobin Li; Wenjie Cai; Kailun Yang
Journal:  PLoS One       Date:  2022-03-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.